18F-FETNIM PET/CT Hypoxia Imaging in Non-Small Cell Lung Cancer: Preliminary Clinical Observation
Ling Li,Man Hu,Wei Zhao,Jinbo Yue,Guoren Yang,Shuqiang Zhao,Jinming Yu
DOI: https://doi.org/10.1007/s10330-010-0622-5
2010-01-01
Abstract:The aims of this study were to evaluate potential side effects of 18F-fluoroerythronitroimidazole (18F-FETNIM) as a new-type hypoxia-imaging agent and to investigate the feasibility of 18F-FETNIM PET imaging in advanced non-small cell lung cancer (NSCLC) patients and the correlations of hypoxia extent with tumor volume or pathological type.
What problem does this paper attempt to address?